myTI | Indus Appstore | App Icon

myTI

myti

Verified

4

Rating

51 MB

Download size

88 MB

Install size
myTI | Indus Appstore | Screenshot
myTI | Indus Appstore | Screenshot
myTI | Indus Appstore | Screenshot
myTI | Indus Appstore | Screenshot
myTI | Indus Appstore | Screenshot
myTI | Indus Appstore | Screenshot
myTI | Indus Appstore | Screenshot
myTI | Indus Appstore | Screenshot

About App

The myTI application is a mobile extension of Trial Interactive, a TransPerfect Life Sciences cloud based e-clinical platform. Trial Interactive was designed by clinical professionals for clinical professionals to meet the end-to-end needs of the clinical trial lifecycle. For the first iteration, myTI enhances the Trial Interactive eTMF module, placing key eTMF processes at the fingertips of study teams at all times. Document capture, query and resolution is essential to a trial’s success and for the health of the eTMF.

Building on the Trial Interactive mission to streamline and simplify global product development, myTI reduces the need to transport large quantities of paper for scanning and expedites the upload of documents. Users can login via their biometric login and safely capture documents with their device camera without storing images on the device itself. Captured images are easily uploaded and coded directly to the eTMF. myTI provides constant access to document query and site statuses so users can proactively manage study documentation and data. Users can experience key advantages of eTMF anytime, anywhere they need it. The mobile experience provides role-specific access for all study professionals (CRAs, project managers, TMF leads, etc.).

Developer info


Similar apps


Popular apps

Indus Appstore

Indus Appstore Private Limited

(Formerly known as ‘OSLabs Technology (India) Private Limited’)
CIN - U74120KA2015PTC174871

Registered Address:

Office-2, Floor 4, Wing B, Block A, Salarpuria Softzone, Bellandur Village, Varthur Hobli, Outer Ring Road, Bangalore South, Bangalore, Karnataka, India, 560103


Disclaimer: All trademarks are property of their respective owners.
For any questions or feedback, reach out to us at [email protected]